ClinicalTrials.govpublic full text
Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma
local progression or metastatic melanoma with failed first-line treatment, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 861179
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.